Journal articleBehav Brain Res · November 21, 2008
Featured Publication
Apolipoprotein (apo) E4, one of three human apoE (h-apoE) isoforms, has been identified as a major genetic risk factor for Alzheimer's disease and for cognitive deficits associated with aging. However, the biological mechanisms involving apoE in learning a ...
Full textLink to itemCite
Journal articleJ Stroke Cerebrovasc Dis · September 2008
Featured Publication
Previous studies show that APOE *4 carriers are at increased risk for ischemic stroke and intracerebral hemorrhage (ICH). The APOE *4 gene is also linked to increased incidence of cerebral amyloid angiopathy. It has been suggested that apolipoprotein E4 ex ...
Full textLink to itemCite
Journal articleNeurobiol Aging · December 2007
Featured Publication
Mortalin is a chaperone protein associated with cell survival, stress response, intracellular trafficking, control of cell proliferation, mitochondrial biogenesis, and cell fate determination. Human APOE targeted replacement (TR) mice have been used to elu ...
Full textLink to itemCite
Journal articleNeurobiol Aging · August 2007
Featured Publication
Autosomal dominant mutations that increase amyloid-beta(1-42) (Abeta42) cause familial Alzheimer's disease (AD), and the most common genetic risk factor for AD is the presence of the epsilon4 allele of apolipoprotein E (apoE). Previously, we characterized ...
Full textLink to itemCite
Journal articleJ Lipid Res · April 2007
Featured Publication
Withdrawing growth factors or serum from endothelial cells leads to the activation of effector caspases 3 and 7, resulting in apoptotic cell death. HDL protects against caspase induction through sphingosine-1-phosphate (S1P) receptors. This anti-caspase ac ...
Full textLink to itemCite
Journal articleNeuroscience · February 23, 2007
Featured Publication
Apolipoprotein E (apoE) modifies glial activation and the CNS inflammatory response in an isoform-specific manner. Peptides derived from the receptor-binding region of apoE have been demonstrated to maintain the functional activity of the intact protein, a ...
Full textLink to itemCite
Journal articleHippocampus · 2007
Featured Publication
Hormone replacement therapy to treat or prevent Alzheimer Disease (AD) in postmenopausal women is controversial because it may pose other health risks such as cancer and thromboembolism. ApoE status is thought to influence the nootropic efficacy of hormone ...
Full textLink to itemCite
Journal articleNeurosci Lett · July 31, 2006
Featured Publication
Amyloid-beta (Abeta) is causally implicated in Alzheimer's disease and neuroplasticity failure has acquired validity as a possible mechanism of early AD pathogenesis. We have previously demonstrated that oligomeric Abeta(1-42) inhibits LTP in the dentate g ...
Full textLink to itemCite
Journal articleNeurobiol Dis · March 2006
Featured Publication
The epsilon4 allele of apolipoprotein (apo)E associates with an increased risk of developing Alzheimer's disease (AD) as well as an earlier age of onset. However, the exact mechanisms by which apoE4 confers such susceptibility is currently unknown. We used ...
Full textLink to itemCite
Journal articleProc Natl Acad Sci U S A · August 16, 2005
Featured Publication
Age-related macular degeneration (AMD) is a late-onset, multifactorial, neurodegenerative disease of the retina and the leading cause of irreversible vision loss in the elderly in the Western world. We describe here a murine model that combines three known ...
Full textLink to itemCite
Journal articleJ Biol Chem · July 8, 2005
Featured Publication
Apolipoprotein E (apoE), a chaperone for the amyloid beta (Abeta) peptide, regulates the deposition and structure of Abeta that deposits in the brain in Alzheimer disease (AD). The primary apoE receptor that regulates levels of apoE in the brain is unknown ...
Full textLink to itemCite
Journal articleBehav Brain Res · April 15, 2005
Featured Publication
Apolipoprotein E4 (apoE4), one of the three most common human apoE (h-apoE) isoforms, is a major genetic risk factor for Alzheimer's disease and for cognitive deficits associated with aging. The biological mechanisms involving apoE in learning and memory p ...
Full textLink to itemCite
Journal articleNeurobiol Dis · March 2005
Featured Publication
The human APOE*4 allele is associated with an early age of onset and increased risk of Alzheimer's disease (AD). Long before the onset of AD, cognitive deficits can be identified in APOE*4 carriers. We examined neurons in the lateral amygdala of young apol ...
Full textLink to itemCite
Journal articleNeurobiol Dis · 2005
Featured Publication
The apolipoprotein E (apoE) genotype is an important genetic risk factor for Alzheimer's disease (AD). In the central nervous system (CNS), most apoE is produced by astrocytes and is present in unique high-density lipoprotein (HDL)-like particles that have ...
Full textLink to itemCite
Journal articleNeuroscience · 2004
Featured Publication
We used three human apolipoprotein (apo) E targeted replacement mouse lines, each expressing one of the three common human apoE isoforms to study the pattern of apoE expression in the central nervous system (CNS). Immunocytochemistry on brain sections from ...
Full textLink to itemCite
Journal articleNeurochem Int · 2001
Featured Publication
The varepsilon4 allele of apolipoprotein E (apoE) is a genetic risk factor for Alzheimer's disease (AD). In order to gain a better understanding of the molecular mechanisms by which apoE and possibly other apolipoproteins produced in the central nervous sy ...
Full textLink to itemCite
Journal articleJ Clin Invest · June 1999
Featured Publication
We have generated mice expressing the human apo E4 isoform in place of the endogenous murine apo E protein and have compared them with mice expressing the human apo E3 isoform. Plasma lipid and apolipoprotein levels in the mice expressing only the apo E4 i ...
Full textLink to itemCite
Journal articleJ Clin Invest · July 1, 1998
Featured Publication
To study isoform-specific effects of apolipoprotein E (apoE) in vivo, we generated mice with a human APOE*2 allele in place of the mouse Apoe gene via targeted gene replacement in embryonic stem cells. Mice expressing human apoE2 (2/2) have virtually all t ...
Full textLink to itemCite
Journal articleJ Biol Chem · July 18, 1997
Featured Publication
Apolipoprotein (apo) E, a constituent of several lipoproteins, is a ligand for the low density lipoprotein receptor, and this interaction is important for maintaining cholesterol and triglyceride homeostasis. We have used a gene replacement strategy to gen ...
Full textLink to itemCite